Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
(NASDAQ:WINT), 1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039 WARRINGTON, Pa., July 02, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, […]